Skip to content

Vicharchikari Taila in treatment of Vicharchika

Pharmaceutical Standardization And clinical Evaluation On Vicharchikari Taila In The Management Of Vicharchika. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071580
Enrollment
30
Registered
2024-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Post Graduate Institue Of Ayurved, Jodhpur, Rajasthan
Lead Sponsor
Dr Palak Sharma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients 14-70 years of both sexes will be selected 2. Patients fulfilling the criteria of classical symptoms of Vicharchika like Kandu (Itching), Pidika (Papillae), Shyavavarna (Discoloration), Daha (Burning sensation), Rukshta (Dryness) and Ruja (Pain) will be selected for assessment. 3.Patients having complaints for less than 5 years.

Exclusion criteria

Exclusion criteria: 1.Patients below 14 and above 70 years. 2.Patients having complaints for more than 5 year. 3.Patients having pregnancy 4.Patient having any allergic history or sensitivity will be excluded from study 5.Patient having diabetes, will be excluded from present study.

Design outcomes

Primary

MeasureTime frame
Relive in classical symptoms of Vicharchika.Timepoint: 60 days

Secondary

MeasureTime frame
Repigmentation and decrease in relapsing lesion of atopic dermatitis.Timepoint: 60 days

Countries

India

Contacts

Public ContactDr Palak Sharma

Postgraduate Institute Of Ayurveda

dr.govindshukla@yahoo.com08769058254

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026